Grace Capital’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Grace Capital’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-23,400	Closed	-$3.19M	–	279
2020 Q3	$3.19M	Sell	23,400 -1,000	-4%	-$106K	2.47%	8
2020 Q2	$2.36M	Sell	24,400 -25,100	-51%	-$2.09M	2.02%	7
2020 Q1	$2.32M	Sell	49,500 -6,500	-12%	-$417K	2.28%	5
2019 Q4	$4.08M	Sell	56,000 -29,500	-35%	-$1.79M	3.33%	4
2019 Q3	$4.46M	Sell	85,500 -8,500	-9%	-$452K	4.5%	3
2019 Q2	$4.71M	Buy	94,000 +70,500	+300%	+$3.43M	2.25%	5
2019 Q1	$1.22M	Sell	23,500 -88,704	-79%	-$4.09M	0.48%	67
2018 Q4	$5.66M	Sell	112,204 -9,100	-8%	-$501K	2.63%	3
2018 Q3	$7.91M	Sell	121,304 -56,000	-32%	-$3.29M	3.09%	4
2018 Q2	$8.8M	Buy	+177,304	New	+$8.58M	3.36%	2

Grace Capital's MYOK Position: Q4 2020 in Review

Grace Capital sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 23,400 shares — an estimated $3.19M sold.

Grace Capital first reported a position in MYOK in Q2 2018 and held it in 10 quarters. The position peaked at $8.8M in Q2 2018. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Grace Capital reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Grace Capital sold 23,400 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $3.19M.
Grace Capital first reported a position in MyoKardia, Inc. Common Stock in Q2 2018 and held it in 10 quarters.
Grace Capital's MyoKardia, Inc. Common Stock position peaked at $8.8M in Q2 2018.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Grace Capital's 13F filing for Q4 2020, filed 10 Feb 2021.